Fig. 2From: Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panelDeveloping proposed care pathway. A schematic representation of the steps involved before, during, and after the expert panel meetingsBack to article page